Apogee Biotechnology Corporation

Calculating rank

USPTO Granted Patents = 6

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 46

Loading Chart...

4 inventors (with patents filed for the assignee):

Charles D Smith (6 out of 26 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (2 out of 3 patents)

6 patents: Sort by Forward Citations

1. 12758536 - Combination of a SK2 inhibitor and an inhibitor of a checkpoint pathway, uses and pharmaceutical compositions thereof (2026-10-13),

2. RE49811 - Sphingosine kinase inhibitors (2024-01-23),

3. 8685936 - Sphingosine kinase inhibitor prodrugs (2014-04-01),

4. 8557800 - Sphingosine kinase inhibitors (2013-10-15),

5. 8063248 - Sphingosine kinase inhibitors (2011-11-22),

6. 7338961 - Sphingosine kinase inhibitors (2008-03-04),

Company Overview

Apogee Biotechnology Corporation is a leading biotechnology company focused on developing novel therapies for cancer and other diseases. With a commitment to scientific excellence and innovation, Apogee is dedicated to improving patient outcomes through the discovery and development of cutting-edge treatments. The company's pipeline includes several promising drug candidates in preclinical and clinical development, targeting a range of oncology indications. Visit our website to learn more about our mission and research programs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#3 in Hershey, PA

#1,625 in Pennsylvania

#45,027 in US

Hershey, PA, United States of America

Apogee Biotechnology Corporation

Forward Citations = 46

4 inventors:

Charles D Smith (6 out of 26 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apogee Biotechnology Corporation. Retrieved from https://idiyas.com/company/apogee-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]